Journal of Sleep Medicine and Disorders

Prevalence of Glaucoma in Patients with Obstructive Sleep Apnea

Research Article | Open Access

  • 1. Department of Radiology, National Guard Hospital, King Abdulaziz Medical City, Saudi Arabia
  • 2. Faculty of Medicine, King Abdulaziz University, Saudi Arabia
  • 3. International Medical Center, Jeddah, Saudi Arabia
  • 4. Department of Family and Community Medicine, King Abdulaziz University, Saudi Arabia
  • 5. Department of Ophthalmology, King Abdulaziz University Hospital, Saudi Arabia
  • 6. Sleep Medicine and Research Center, King Abdulaziz University Hospital, Saudi Arabia
+ Show More - Show Less
Corresponding Authors
Siraj Omar Wali, College of Medicine, King Abdulaziz University, Consultant in Pulmonary & Sleep Medicine, Director, Sleep Medicine and Research Center, King Abdulaziz University Hospital, Jeddah 80215, PO BOX 21589, Saudi Arabia, Tel: +966 2 6408258 Fax: +966 2 6408315

Study Objective: To determine the prevalence of glaucoma in obstructive sleep apnea (OSA) patients and compare it with that of patients without OSA.

Methods: Patients investigated for OSA using polysomnography at the sleep center of King Abdulaziz University Hospital were invited to participate in this cross-sectional case series study. American Academy of Sleep Medicine guidelines were used to diagnose OSA. Recruitment of patients with and without OSA was conducted from December 2013 to September 2015.Exclusion criteria included steroid use and presence of other ocular diseases. Two criteria, cup/ disc ratio and visual field defects, were necessary for a glaucoma diagnosis.

Results: Among 84 adults enrolled, 45 (54%) had a confirmed diagnosis of OSA. Glaucoma prevalence was higher among individuals with OSA (16%) than among non-OSA individuals (8%), a difference that was not statistically significant. A consistent trend, which was not statistically significant after adjusting for cofounders, toward more glaucomatous changes was observed in OSA subjects.

Conclusion: Although a trend toward higher glaucoma prevalence was observed in OSA patients, the difference was not statistically significant. Because many variables contribute to the development of the two conditions, larger cohorts are needed to evaluate associations between glaucoma and OSA.


Wafaa G, Mariam M, Halima A, Osama B, Ashfaque M, et al. (2017) Prevalence of Glaucoma in Patients with Obstructive Sleep Apnea. J Sleep Med Disord 4(3): 1084.


•    Frequency; Sleep; Sleep disordered breathing; 
Intraocular pressure


AASM: American Academy of Sleep Medicine; AHI: ApneaHypopnea Index; CCT: Central Corneal Thickness; CD: Cup To Disc; CI: Confidence Interval; CPAP: Continuous Positive Airway Pressure Therapy; BMI: Body Mass Index; ESS: Epworth Sleepiness Scale; IOP: Intraocular Pressure; KAU: King Abdul Aziz University; NTG: Normal Tension Glaucoma; OCT: Optical Coherence Tomography; OD: Right; OR: Odd’s Ratio; OS: Left; OSA: Obstructive Sleep Apnea; OSAS: Obstructive Sleep Apnea Syndrome; POAG: Primary Open Angle Glaucoma; PSG: Polysomnography; SD: Standard Deviation; VF: Visual Field


Glaucoma is a common and serious progressive disease of the optic nerve. It is characterized by optic neuropathy that develops due to the progressive degeneration of retinal ganglion cells and their axons, leading to unique visual field defects and increased cupping of the optic disc [1]. Primary open angle glaucoma (POAG) is estimated to be responsible for 50% of glaucoma cases [2].

When left unnoticed and untreated, glaucoma can lead to blindness, as the changes are irreversible. According to World Health Organization analysis, glaucoma is the second leading cause of blindness worldwide and is responsible for 12.3% of cases [3]. Globally, approximately 60 million people are diagnosed with glaucomatous optic neuropathy, and an estimated 8.4 million people are blind because of glaucoma. These numbers are predicted to increase to 80 million and 11.2 million, respectively, by 2020. Therefore, screening may be pertinent to aid early detection. However, screening the general population may not be cost-effective. Hence, identifying at-risk groups to guide screening efforts for early detection may be worthwhile. Factors associated with glaucoma include elevated intraocular pressure (IOP), low perfusion pressure to the optic disc due to fluctuating systemic blood pressure, advanced age, a thin central cornea, racial background and a positive family history [4]. Glaucoma can still occur in the absence of elevated IOP, which is known as normal tension glaucoma (NTG) [5]. Associations among diabetes mellitus, hypertension, ischemic vascular disorders and glaucoma remain unclear [6]. Gender is not a known risk factor for glaucoma [7].

One area of recent interest is the association between sleep apnea and glaucoma in adults. Obstructive sleep apnea (OSA) syndrome, which affects 3-7% of men and 2-5% of women, is characterized by recurrent episodes of upper airway collapse, resulting in frequent arousal during sleep and hypoxemia [8]. An association between POAG and sleep apnea has recently been proposed [9]. Researchers are still debating whether OSA increases the risk of developing glaucoma or has a direct causative effect. The pathophysiological mechanism underlying the development of glaucoma supports the hypothesis that OSA may play a role in the development or progression of the disease. A link between the two disorders has been postulated to be because of the effect of hypoxia and impaired autoregulation of optic nerve perfusion in OSA [10-12]. A mechanical hypothesis linking increased IOP to the supine position during sleep and obesity has also been proposed [13].

In our study, we aim to determine the prevalence of glaucoma among individuals with OSA and to compare it to that of individuals without OSA. In addition, we explore the association between OSA and glaucoma before and after adjusting for potential confounders among an adult population in a tertiary center in Saudi Arabia.


Study design, participants, and ethics

OSA is defined according to the most recent American Academy of Sleep Medicine (AASM) recommendations (2014), i.e., A- an apnea/hypopnea index (AHI) of ≥15 determined by polysomnography (PSG) or B- an AHI of ≥5 but <15 events, in addition to one of the following: 1) daytime sleepiness, nonrestorative sleep, fatigue or insomnia symptoms; 2) incidences of waking up with gasping or choking sensations; 3) reported snoring, breathing interruptions or both during sleep; or 4) a known history of hypertension, mood or cognitive dysfunction, coronary artery disease, stroke, congestive heart failure, atrial fibrillation or diabetes mellitus. AHI was also used to determine the severity of OSA, as follows: mild (5-15), moderate (15-30) and severe (higher than 30) [14].

Our target population was patients who were referred to the Sleep Medicine and Research Center at King Abdul Aziz University (KAU) Hospital in Jeddah, Saudi Arabia. All patients underwent PSG at the Center. The exclusion criteria were the use of topical and systemic steroids, having a narrow angle of the anterior chamber, or having other ocular inflammatory diseases, cataracts, diabetic retinopathy, or keratoconus. At the time of testing, patients were not using home continuous positive airway pressure therapy (CPAP) or another treatment for OSAS.

Accordingly, 100 subjects diagnosed with OSA were eligible for recruitment, but only 44 agreed to participate (OSA group). Of the 110 subjects who did not have OSA, 39 agreed to be enrolled and met our criteria (OSA-free group). Recruitment was conducted during the period from December 2013 to September 2015. Informed consent was obtained from all participants and approval was granted from the Ethical Committee at KAU Hospital.

Data collection (A flowchart is provided in Figure 1):

Socio-demographic characteristics and medical histories were collected from all patients. All participants underwent a screening visit followed by a confirmatory visit if glaucoma was suspected. In the first screening visit, we measured the bestcorrected visual acuity, IOP by applanation tonometry and cup/ disc (CD) ratio by directly visualizing the fundus with the help of a 78D lens in all subjects. Patients whose CD ratio was greater than 0.3 with or without increased IOP were scheduled for a second screening visit for a visual field assessment.

In the second confirmatory visit, scanning laser polarimetry and optical coherence tomography (OCT) of the optic nerve were used to accurately measure the optic nerve head. Pachymetry was performed to measure the central corneal thickness (CCT) and to exclude a false high IOP (Figure 2). A participant was diagnosed with glaucoma when both an increased CD ratio (>0.3) and characteristic glaucomatous visual field (VF) changes were present [1].


Outcome variables: IOP in the right (OD) and left (OS) eye and the CD ratios in the right and left eye were all used as continuous variables in the analysis. Cupping was defined as a CD ratio >0.3 in at least one eye. Visual field defects characteristic of glaucoma were assessed and reported by a single ophthalmology expert.

Main independent variables: OSA was diagnosed based on a level I overnight polysomnography using the AASM guidelines [14]. OSA was a dichotomous variable (0=no, 1=yes).

Co-variables: A group of variables were considered as potential confounders in the association between OSA and POAG. These factors were: sex (0=male, 1=female), age (continuous in years), body mass index (BMI; continuous in kg/m2 ), a diagnosis of diabetes (0=no, 1=yes) or hypertension (0=no, 1=yes), a family history of glaucoma (0=no, 1=yes), and smoking status (0=non smoker, 1=smoker).

Data analysis

A descriptive overview of the baseline characteristics of the study population is presented. The means and standard deviations for continuous variables and numbers with column percentages for categorical variables were analyzed. Chi-square and independent sample t-tests assuming equal or unequal variances were used as appropriate to assess how the outcome variables differed between the OSA and OSA-free groups. The normality and variance of all the continuous ocular measurement variables were assessed using q-q plots and Levene’s test of the equality of the variances. However, the t-test is considered a robust test, even when the normality assumption is violated. We performed unadjusted and adjusted linear and logistic regression models to assess the association between OSA and glaucoma. Coefficients (for linear regression) and odds ratios (ORs; for logistic regression) with 95% confidence intervals (CIs) are presented. The significance level of the analysis was set at 0.05. All statistical analyses were performed with STATA version 13 (Stata Corp, College Station, TX, USA).


The study sample consisted of 84 adults, 45 (54%) of whom had a confirmed diagnosis of OSA: 8 had mild, 12 had moderate, and 25 had severe OSA. The OSA-free group consisted of 39 individuals. Sixty-five percent of the participants were male. The mean age was 44 years (SD 14.8; range 19 – 76), and the mean BMI was 34 kg/m2 . Demographic characteristics and relevant medical histories of the participants are presented in Table (1). Mean age, BMI and the prevalence of diabetes and hypertension were significantly higher among the OSA group than among the OSA-free group (p<0.05). The respiratory parameters obtained from PSG, including AHI, minimum O2 saturation, mean O2 saturation and percentage of sleep time with O2 saturation less than 90%, are also presented in Table (1).

In Table (2), we present a comparison of the relevant eye examination parameters between participants with OSA and participants without OSA. Individuals with OSA had a significantly higher IOP in the left eye (p<0.05) and a p value close to significance for the IOP level in right eye (p=0.051). The mean CD ratios among subjects with OSA were similar to the ratios of participants without OSA: 0.24 vs. 0.25 in the right eye and 0.25 vs. 0.24 in the left eye, and the p values were not statistically significant. As shown in Table (2), a greater proportion of individuals with OSA were diagnosed with glaucoma (16%) than of participants without OSA (8%). However, the difference was not statistically significant.

Regarding IOP, only one patient was found to be ocular hypertensive (> 21 mm Hg) in the OSAS group, and none of the patients in the control group had elevated IOP. The eye parameters of the group of participants with severe OSA (AHI >30) were an IOP of 14.8for the OD, an IOP of 15.1 for the OS, a CD ratio of 0.26 for the OD, and a CD ratio of 0.27 for the OS. A comparison of those parameters to the parameters measured in individuals without OSA (not presented in a table) shows a similar trend as the findings presented in Table (2). The only significant difference was observed for IOP of the OS (p=0.033).

In Table (3), we present the findings of unadjusted and adjusted regression models assessing the association between glaucoma, eye exam parameters and OSA. Each outcome is regressed individually, first with regard to the OSA status without adjusting for confounders and then after controlling for age, sex, BMI, smoking, diabetes, hypertension, and a family history of glaucoma. ORs associated with having a diagnosis of glaucoma for OSA patients compared to OSA-free individuals were 2.21 (crude OR) and 1.71 (adjusted OR), which were not statistically significant. The only significant coefficient from the linear regression models was the IOP for OS (p<0.05) in which individuals with OSA had a significant increase in their IOP, but the difference was not statistically significant after adjusting for confounders.


In this study, the prevalence of glaucoma in the OSA group was higher than in the OSA-free group (16% vs. 8%). However, this difference was not statistically significant. The prevalence of glaucoma in the OSA-free group (8%) was higher than the value published in 2014for the normal population in the “Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040” meta-analysis (3.54%) [15]. Our higher prevalence may be attributable to the different cohort of patients used in our study, as all the patients who were referred were suspected of having sleep disorders. Another explanation may be the larger sample size utilized in the global study [15].

In our study, the prevalence of glaucoma among the OSA group was higher than that reported in similar studies conducted in Switzerland, Italy, Taiwan and Turkey but less than that reported in the United States (Table 4). This finding may indicate a racial contribution in the development of POAG in patients with OSA. People of African ancestry are more likely to develop glaucoma than people of European ancestry [16].

Accumulating evidence links OSA and POAG [17-19], as well as NTG [20-23].However, other research studies did not observe an association between OSA and POAG [24-28]. A recent study by [29] systematically reviewed the publications assessing an association between OSA and glaucoma. The authors performed a meta-analysis of six case-control and nine cross-sectional studies, as well as the results of a large retrospective cohort study. The pooled results showed that patients with OSA had a higher risk of developing glaucoma than patients without OSA [29]. However, as mentioned in the review, only four of the 16 studies included in the meta-analysis controlled for potential confounders, and all four studies showed a non-significant association when examined alone [29]. Therefore, we have reason to believe that an association between OSA and glaucoma is still a matter of debate, and additional studies with sufficient power as well as proper measurement and control of important confounders are needed.

The link between the two disorders has been postulated due to the effects of hypoxia and the impaired auto regulation of optic nerve perfusion in OSA [10-12]. A mechanistic hypothesis linking the increased IOP to the supine position during sleep and obesity has also been proposed [13].

Cardiovascular disease, obesity and male gender are important risk factors for OSA [30,31]. In our study, the members of the OSA group had a higher mean BMI, were more likely to be diabetic and to be receiving treatment for hypertension and were more likely to be male than the members of the control group (p value<0.05). These co-morbidities are also risk factors for glaucoma [6] and may contribute to our finding of a higher prevalence of glaucoma in the OSA group. In addition, aging is a risk factor for glaucoma. In the study by Al Mansouri et al, patients in the 60 year age group were more likely to develop glaucoma [32]. In our study, the ages of patients diagnosed with glaucoma ranged from 42-60. Patients diagnosed with POAG were older (mean age: 51.6 years) than patients without glaucoma (mean age: 35.4 years; p value<0.05).

Furthermore, we explored the association between OSA and glaucoma before and after adjusting for potential confounders (Table 3). A consistent trend toward more glaucomatous changes was observed in participants with OSA; however, these changes were not statistically significant after adjusting for cofounders. The lack of a significant difference may be due to the small sample size and hence the lack of power.

In 1982, Walsh and Montplaisir first noticed an association between OSA and glaucoma in five patients in two generations within the same family [33]. However, we did not find an increased risk attributable to a family history of glaucoma. This finding is not surprising, as glaucoma is believed to be caused by multiple inherited and environmental factors [4].

POAG treatments are directed towards lowering the IOP and include pharmacotherapy, laser therapy and surgery. As POAG is a progressive disease, the consequence of late diagnosis is further optic nerve damage and eventual blindness [34]. However, controversy exists regarding whether treating OSA improves POAG, as some studies show a positive effect and others show worsening outcomes [35].

Table 1: Characteristics of the study population.

Variables OSAS p
Age in years (mean ± SD) 35.4±13 51.6 ±12 <0.001
Sex, n (%)
Male 21 (54) 34 (76) 0.037
Female 18 (46) 11(24)  
BMI in m2/kg (mean ± SD) 30.1±9 37.4±9 <0.001
Smoking status, n (%)
Non- or ex-smoker 30 (79) 38 (84) 0.517
Smoker 8 (21) 7 (16)  
Diabetes, n (%)
No 32 (82) 25 (56) 0.010
Yes 7 (18) 20 (44)  
Hypertension, n (%)
No 29 (74) 13 (29) <0.001
Yes 10 (26) 32 (71)  
Family history of glaucoma, n (%)
No 32 (82) 41 (91) 0.220
Yes 7 (18) 4 (9)  
AHI (mean ± SD) 2.3±1.7 36.2±21.5 <0.001
Minimum O2 saturation (mean ± SD) 88.2±8.7 74.7±13.6 <0.001
Mean O2 saturation (mean ± SD) 95.6±2.2 90.2±7.8 <0.001
% Sleep time with O2saturation less than 90% (mean ± SD) 1.7±6.8 33.3±37.3 <0.001
ESS score (mean ± SD) 11.1±6.2 11.9±5.1 0.528

Table 2: Comparison of glaucoma diagnosis and eye parameters in individuals with and without OSAS. Continuous variables are presented as means with standard deviations, and categorical variables are presented as n and column percentages.

Variables OSAS p
IOP of the OD (mean ± SD) 13±3.7 14.5±3.4 0.052
IOP of the OS (mean ± SD) 13.1±3.3 14.8±3.3 0.023
CD ratio of the OD (mean ± SD) 0.25±0.15 0.24±0.20 0.892
CD ratio of the OS (mean ± SD) 0.24±0.13 0.25±0.22 0.760
Cupping >0.3 in either eye, n(%) 7 (18 8 (18) 0.984
Glaucoma diagnosis, n (%) 3 (8) 7 (16) 0.267

Table 3: Unadjusted and adjusted coefficients and ORs of eye exam parameters and glaucoma diagnosis for OSAS status (coefficients are presented with 95% CIs in parentheses, n=84).

Continuous Outcomes OSAS
(95% CI)
(95% CI)
IOP of the OD 1.51
(-0.02 to 3.04)
(-1.2 to 2.9)
IOP of the OS 1.68*
(0.23 to 3.12)
(-0.91 to 3.07)
CD ratio of the OD -0.005
(-0.08 to 0.07)
(-0.16 to 0.05)
CD ratio of the OS 0.01
(-0.07 to 0.09)
(-0.15 to 0.08)
Categorical Outcomes Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Cupping OSA No 1.00 1.00
Yes 0.99
(0.32 3.03)
(0.15 – 3.35)
Glaucoma OSA No 1.00 1.00
Yes 2.21
(0.53 – 9.21)
(0.25 – 11.6)
#The adjusted model was adjusted for: age, sex, BMI, smoking, diabetes, hypertension, and a family history of glaucoma.
IOP: Intra Ocular Pressure; CD Ratio, Cup to Disc Ratio; OR: Odds Ratio



The main limitation of observation studies is the potential imbalance with regard to baseline characteristics between the two groups compared. One way to address this limitation is to adjust for baselines characteristics in a regression analysis model, which we performed in this study. Each outcome is regressed individually, first for OSAS status without adjusting for confounders and then after controlling for age, sex, BMI, smoking, diabetes, hypertension, and a family history of glaucoma. The ORs for individuals with OSAS who were diagnosed with glaucoma were 2.21 (crude OR) and 1.71 (adjusted OR).

Due to the difficulty we encountered in recruiting patients, the sample size was smaller than we originally planned, which limited our analysis of prevalence. In addition, the control group was younger than the OSAS group; thus, we could not control for age in the selected subjects.

Lastly, bias might exist in patient selection, rendering patients who are in a tertiary center (as in ours) to be systematically different from those who are in primary care. Therefore, this study cannot be generalized to all OSAS patients. We recommend further research in primary care and community settings.


Although we observed a trend toward a higher prevalence of glaucoma among patients with OSA compared to the non-OSA group, the difference was not statistically significant. As many variables contribute to the development of the two conditions, larger cohorts are required to evaluate the association between glaucoma and OSA.


Special thanks are extended to the Sleep Medicine and Research Center and Ophthalmology Department for their help. This work would not have been possible without the assistance of the nursing staff in the Sleep Lab and the Ophthalmology Clinics. The research was financed and supported by the Sleep Medicine and Research Center at King Abdulaziz University.


1. American Optometric Association Original Consensus Panel on Care of the Patient with Open Angle Glaucoma, Mancil GL, Bailey IL, Brookman KE, Campbell JB, Cho MH, et al. Care of the patient with open angle glaucoma. St. Louis, MO: American Optometric Association; 2010.

2. Cook C, Foster P. Epidemiology of glaucoma: what’s new? Can J Ophthalmol. 2012; 47: 223-226.

3. Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82: 844-851.

4. Worley A, Grimmer-Somers K. Risk factors for glaucoma: what do they really mean? Aust J Prim Health. 2011; 17: 233-239.

5. Lee BL, Bathija R, Weinreb RN. The definition of normal-tension glaucoma. J Glaucoma. 1998; 7: 366-371.

6. Emanuel ME, Gedde SJ. Indications for a systemic work-up in glaucoma. Can J Ophthalmol. 2014; 49: 506-511.

7. Tielsch JM. The epidemiology and control of open angle glaucoma: a population-based perspective. Annu Rev Public Health. 1996; 17: 121- 136.

8. Lurie A. Obstructive sleep apnea in adults: epidemiology, clinical presentation, and treatment options. Adv Cardiol. 2011; 46: 1-42.

9. McNab AA. The eye and sleep apnea. Sleep Med Rev. 2007; 11: 269- 276.

10. Dhillon S, Shapiro CM, Flanagan J. Sleep-disordered breathing and effects on ocular health. Can J Ophthalmol 2007; 42: 238-243.

11. Faridi O, Park SC, Liebmann JM, Ritch R. Glaucoma and obstructive sleep apnoea syndrome. Clin Exp Ophthalmol. 2012; 40: 408-419.

12. Fraser CL. Obstructive sleep apnea and optic neuropathy: is there a link? Curr Neurol Neurosci Rep. 2014; 14: 465.

13. Keenan TD, Goldacre R, Goldacre MJ. Associations between obstructive sleep apnoea, primary open angle glaucoma and age-related macular degeneration: record linkage study. Br J Ophthalmol. 2017; 101: 155- 159.

14. American Academy of Sleep Medicine. International Classification of Sleep Disorders. Darien: American Academy of Sleep Medicine. 2014.

15. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121: 2081-2090.

16. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt JC, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991; 325: 1412-1417.

17. Boyle-Walker M, Semes LP, Clay OJ, Liu L, Fuhr P. Sleep apnea syndrome represents a risk for glaucoma in a veterans’ affairs population. ISRN Ophthalmol. 2011; 2011: 920767.

18. Lin CC, Hu CC, Ho JD, Chiu HW, Lin HC. Obstructive sleep apnea and increased risk of glaucoma: a population-based matched-cohort study. Ophthalmology. 2013; 120: 1559-1564.

19. Onen SH, Mouriaux F, Berramdane L, Dascotte JC, Kulik JF, Rouland JF. High prevalence of sleep-disordered breathing in patients with primary open-angle glaucoma. Acta Ophthalmol Scand. 2000; 78: 638- 641.

20. Bilgin G. Normal-tension glaucoma and obstructive sleep apnea syndrome: a prospective study. BMC Ophthalmol. 2014; 14: 27.

21. Lin PW, Friedman M, Lin HC, Chang HW, Wilson M, Lin MC. Normal tension glaucoma in patients with obstructive sleep apnea/hypopnea syndrome. J Glaucoma. 2011; 20: 553-558.

22. Marcus DM, Costarides AP, Gokhale P, Papastergiou G, Miller JJ, Johnson MH, et al. Sleep disorders: a risk factor for normal-tension glaucoma? J Glaucoma. 2001; 10: 177-183.

23. Sergi M, Salerno DE, Rizzi M, Blini M, Andreoli A, Messenio D, et al. Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients. J Glaucoma. 2007; 16: 42-46.

24. Aptel F, Chiquet C, Tamisier R, Sapene M, Martin F, Stach B, et al. Association between glaucoma and sleep apnea in a large French multicenter prospective cohort. Sleep Med. 2014; 15: 576-581.

25. Geyer O, Cohen N, Segev E, Rath EZ, Melamud L, Peled R, et al. The prevalence of glaucoma in patients with sleep apnea syndrome: same as in the general population. Am J Ophthalmol. 2003; 136: 1093-1096.

26. Khandgave TP, Puthran N, Ingole AB, Nicholson AD. The assessment of sleep apnoea as a risk factor in glaucoma. J Clin Diagn Res. 2013; 7: 1391-1393.

27. Roberts TV, Hodge C, Graham SL, Burlutsky G, Mitchell P. Prevalence of nocturnal oxygen desaturation and self-reported sleep-disordered breathing in glaucoma. J Glaucoma. 2009; 18: 114-118.

28. Stein JD, Kim DS, Mundy KM, Talwar N, Nan B, Chervin RD, et al. The association between glaucomatous and other causes of optic neuropathy and sleep apnea. Am J Ophthalmol. 2011; 152: 989-998.

29. Shi Y, Liu P, Guan J, Lu Y, Su K. Association between glaucoma and obstructive sleep apnea syndrome: a meta-analysis and systematic review. PLoS One. 2015; 10.

30. Lee W, Nagubadi S, Kryger MH, Mokhlesi B. Epidemiology of obstructive sleep apnea: a population-based perspective. Expert Rev Respir Med. 2008; 2: 349-364.

31. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008; 5: 136-143.

32. Al-Mansouri FA, Kanaan A, Gamra H, Khandekar R, Hashim SP, Al Qahtani O, et al. Prevalence and determinants of glaucoma in citizens of qatar aged 40 years or older: a community-based survey. Middle East Afr J Ophthalmol. 2011; 18: 141-149.

33. Walsh JT, Montplaisir J. Familial glaucoma with sleep apnoea: a new syndrome? Thorax. 1982; 37: 845-849.

34. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004; 363: 1711-1720.

35. Kadyan A, Asghar J, Dowson L, Sandramouli S. Ocular findings in sleep apnoea patients using continuous positive airway pressure. Eye (Lond). 2010; 24: 843-850.

Received : 25 Oct 2017
Accepted : 14 Dec 2017
Published : 16 Dec 2017
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
TEST Journal of Dentistry
ISSN : 1234-5678
Launched : 2014
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X